Jazz Pharmaceuticals Inc. on Tuesday reported first quarter net income of $21.8 million, or 48 cents a share, compared to $1.5 million, or 4 cents a share in the same period last year.
Palo Alto-based Jazz (NASDAQ:JAZZ) reported revenue of $50.9 million, up from the year-ago quarter's $35.2 million.
No comments:
Post a Comment